SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-052465
Filing Date
2023-11-09
Accepted
2023-11-09 16:21:16
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20012470_10q.htm   iXBRL 10-Q 2167789
2 EXHIBIT 31.1 ef20012470_ex31-1.htm EX-31.1 12483
3 EXHIBIT 31.2 ef20012470_ex31-2.htm EX-31.2 12425
4 EXHIBIT 32.1 ef20012470_ex32-1.htm EX-32.1 4985
5 EXHIBIT 32.2 ef20012470_ex32-2.htm EX-32.2 5852
  Complete submission text file 0001140361-23-052465.txt   8242272

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA knte-20230930.xsd EX-101.SCH 40053
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE knte-20230930_cal.xml EX-101.CAL 48488
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE knte-20230930_def.xml EX-101.DEF 210062
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE knte-20230930_lab.xml EX-101.LAB 552796
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knte-20230930_pre.xml EX-101.PRE 359535
61 EXTRACTED XBRL INSTANCE DOCUMENT ef20012470_10q_htm.xml XML 1538169
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Filer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39743 | Film No.: 231392827
SIC: 2834 Pharmaceutical Preparations